Directed Evolution of Copper-Substituted Nonheme Enzymes for Enantioselective Alkene Oxytrifluoromethylation
Journal of the American Chemical Society · 20.08.2025 · 147 (33) · 29624-29630
DOI: 10.1021/jacs.4c18532 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of the American Chemical Society, online erschienen am 05.08.2025. Verfasst von James G Zhang und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, Johns Hopkins University; Baltimore, Maryland 21218, United States. Hauptthemen laut MEDLINE: Copper, Alkenes, Directed Molecular Evolution. Die Arbeit wurde bisher 28-mal zitiert (Crossref) und nennt 70 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIGMS NIH HHS, National Institute of General Medical Sciences.
Abstract (Originalsprache)
Trifluoromethylation is a coveted transformation due to the unique properties of the trifluoromethyl (-CF3) group and the importance of organofluorine compounds. Enzymes that can catalyze the formation of C-CF3 bonds would therefore be highly desirable. However, such "trifluoromethylases" are rare. Here, we report a biocatalytic platform for constructing CF3-substituted lactones via intramolecular alkene oxytrifluoromethylation based on hydroxymandelate synthase from Amycolatopsis orientalis (AoHMS), a nonheme iron enzyme. The key feature that enabled the development of this enzymatic system was the substitution of the native catalytic iron center with copper. This modification retained the ability of the AoHMS protein scaffold to facilitate CF3 radical generation while harnessing the exceptional catalytic activity of copper for alkene oxyfunctionalizations. Directed evolution of copper-substituted AoHMS resulted in an engineered variant capable of producing β-, γ-, and δ-lactones bearing quaternary stereocenters with high efficiency and enantiocontrol (up to 99% yield and 98.5:1.5 e.r.). This work not only expands the biocatalytic toolbox for organofluorine synthesis but also highlights the immense potential of metal-substituted nonheme iron enzymes for evolving new-to-nature transformations.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Chemistry, Johns Hopkins University; Baltimore, Maryland 21218, United States.
ORCID-Profile: James G Zhang, Xiongyi Huang
Förderung
- NIGMS NIH HHS
- National Institute of General Medical Sciences
Zitieren
APA
Zhang, J. G., & Huang, X. (2025). Directed Evolution of Copper-Substituted Nonheme Enzymes for Enantioselective Alkene Oxytrifluoromethylation. Journal of the American Chemical Society, 147(33), 29624-29630. https://doi.org/10.1021/jacs.4c18532
Vancouver
Zhang JG, Huang X. Directed Evolution of Copper-Substituted Nonheme Enzymes for Enantioselective Alkene Oxytrifluoromethylation. Journal of the American Chemical Society. 2025;147(33):29624-29630. doi:10.1021/jacs.4c18532
BibTeX
@article{Zhang2025,
author = {Zhang, James G and Huang, Xiongyi},
title = {Directed Evolution of Copper-Substituted Nonheme Enzymes for Enantioselective Alkene Oxytrifluoromethylation},
journal = {Journal of the American Chemical Society},
year = {2025},
volume = {147},
number = {33},
pages = {29624--29630},
doi = {10.1021/jacs.4c18532}
}
EUVIMED